The reason for having a code of pharmaceutical ethics: Spanish Pharmacists Code of Ethics

by Ana Mulet Alberola, Dolores Barreda Hernández, Diana González Bermejo, Enrique Soler Company
Published 2017-05-01

Impact of the economic crisis on the activity of a clinical research ethics committee; response from the Spanish Agency of Medicines and Medical Devices

by Diana González Bermejo, Diego Macías Saint-Gerons, César de la Fuente Honrubia, Dolores Montero Corominas
Published 2015-07-01

EVOLUCIÓN DEL USO DE MEDICAMENTOS ANSIOLÍTICOS E HIPNÓTICOS EN ESPAÑA DURANTE EL PERÍODO 2000-2011

by Maria Pilar Vicente Sánchez, Diego Macías Saint-Gerons, Diana González Bermejo, Dolores Montero Corominas, Ferrán Catalá-López, César de la Fuente Honrubia
Published 2013-01-01

Perfil Clínico-Epidemiológico de Pacientes que inician Terapia Intensiva con Estatinas para La Prevención Secundaria de Enfermedad Vascular en España

by Diego Macías Saint Gerons, César de la Fuente Honrubia, Diana González Bermejo, Dolores Montero, Miguel J. Gil, Antonio Salvador Sanz, Fernando de Andrés Trelles, Ferrán Catalá López
Published 2015-01-01

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.

by Ferrán Catalá-López, Diego Macías Saint-Gerons, Diana González-Bermejo, Giuseppe M Rosano, Barry R Davis, Manuel Ridao, Abel Zaragoza, Dolores Montero-Corominas, Aurelio Tobías, César de la Fuente-Honrubia, Rafael Tabarés-Seisdedos, Brian Hutton
Published 2016-03-01